Your browser doesn't support javascript.
loading
Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy.
Rocha, Eduardo Arrais; Pereira, Francisca Tatiana Moreira; Abreu, José Sebastião; Lima, José Wellington O; Monteiro, Marcelo de Paula M; Rocha Neto, Almino Cavalcante; Quidute, Ana Rosa Pinto; Goés, Camilla Viana A; Rodrigues Sobrinho, Carlos Roberto Martins; Scanavacca, Maurício Ibrahim.
Afiliação
  • Rocha EA; Universidade de São Paulo, São Paulo, SP, Brazil.
  • Pereira FT; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Abreu JS; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Lima JW; Universidade Estadual do Ceará, Fortaleza, CE, Brazil.
  • Monteiro Mde P; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Rocha Neto AC; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Quidute AR; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Goés CV; Universidade de São Paulo, São Paulo, SP, Brazil.
  • Rodrigues Sobrinho CR; Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Scanavacca MI; Universidade de São Paulo, São Paulo, SP, Brazil.
Arq Bras Cardiol ; 105(6): 552-9, 2015 Dec.
Article em En, Pt | MEDLINE | ID: mdl-26351981
BACKGROUND: Cardiac resynchronization therapy (CRT) is the recommended treatment by leading global guidelines. However, 30%-40% of selected patients are non-responders. OBJECTIVE: To develop an echocardiographic model to predict cardiac death or transplantation (Tx) 1 year after CRT. METHOD: Observational, prospective study, with the inclusion of 116 patients, aged 64.89 ± 11.18 years, 69.8% male, 68,1% in NYHA FC III and 31,9% in FC IV, 71.55% with left bundle-branch block, and median ejection fraction (EF) of 29%. Evaluations were made in the pre­implantation period and 6-12 months after that, and correlated with cardiac mortality/Tx at the end of follow-up. Cox and logistic regression analyses were performed with ROC and Kaplan-Meier curves. The model was internally validated by bootstrapping. RESULTS: There were 29 (25%) deaths/Tx during follow-up of 34.09 ± 17.9 months. Cardiac mortality/Tx was 16.3%. In the multivariate Cox model, EF < 30%, grade III/IV diastolic dysfunction and grade III mitral regurgitation at 6­12 months were independently related to increased cardiac mortality or Tx, with hazard ratios of 3.1, 4.63 and 7.11, respectively. The area under the ROC curve was 0.78. CONCLUSION: EF lower than 30%, severe diastolic dysfunction and severe mitral regurgitation indicate poor prognosis 1 year after CRT. The combination of two of those variables indicate the need for other treatment options.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração / Medição de Risco / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En / Pt Revista: Arq Bras Cardiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração / Medição de Risco / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En / Pt Revista: Arq Bras Cardiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil